IS6914A - 2-þíó-útskiptar imídasólafleiður og notkun þeirraí lyfjaiðnaðinum - Google Patents

2-þíó-útskiptar imídasólafleiður og notkun þeirraí lyfjaiðnaðinum

Info

Publication number: IS6914A
Authority: IS; Iceland
Prior art keywords: sub; thio; imidazole derivatives; substituted imidazole; pharmaceutical industry
Prior art date: 2001-02-19

Application number

IS6914A

Other languages

English (en)

Inventor

Laufer Stefan

Kotschenreuther Dunja

Merckle Philipp

Tollmann Karola

Striegel Hans-Günter

Original Assignee

Merckle Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-19

Filing date

2003-08-15

Publication date

2003-08-15

2003-08-15 Application filed by Merckle Gmbh filed Critical Merckle Gmbh

2003-08-15 Publication of IS6914A publication Critical patent/IS6914A/is

Links

150000002460 imidazoles Chemical class 0.000 title abstract 2
229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title abstract 2
102000004127 Cytokines Human genes 0.000 abstract 1
108090000695 Cytokines Proteins 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
230000002519 immonomodulatory effect Effects 0.000 abstract 1
210000000987 immune system Anatomy 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Virology (AREA)
Oncology (AREA)
Diabetes (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Heart & Thoracic Surgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)
Dermatology (AREA)
Psychiatry (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Endocrinology (AREA)
Hematology (AREA)
Transplantation (AREA)

IS6914A 2001-02-19 2003-08-15 2-þíó-útskiptar imídasólafleiður og notkun þeirraí lyfjaiðnaðinum IS6914A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10107683A DE10107683A1 (de)	2001-02-19	2001-02-19	2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie
PCT/EP2002/001746 WO2002066458A2 (de)	2001-02-19	2002-02-19	2-thio-substituierte imidazolderivate und ihre verwendung in der pharmazie

Publications (1)

Publication Number	Publication Date
IS6914A true IS6914A (is)	2003-08-15

Family

ID=7674545

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6914A IS6914A (is)	2001-02-19	2003-08-15	2-þíó-útskiptar imídasólafleiður og notkun þeirraí lyfjaiðnaðinum

Country Status (22)

Country	Link
US (1)	US7253191B2 (is)
EP (1)	EP1362045B1 (is)
JP (1)	JP2004521913A (is)
KR (1)	KR100642231B1 (is)
CN (1)	CN1291984C (is)
AT (1)	ATE282605T1 (is)
AU (1)	AU2002247726C1 (is)
BR (1)	BR0207254A (is)
CA (1)	CA2453078A1 (is)
CZ (1)	CZ20032224A3 (is)
DE (2)	DE10107683A1 (is)
DK (1)	DK1362045T3 (is)
ES (1)	ES2233808T3 (is)
HU (1)	HUP0303155A3 (is)
IL (1)	IL157050A0 (is)
IS (1)	IS6914A (is)
MX (1)	MXPA03007380A (is)
PL (1)	PL367397A1 (is)
PT (1)	PT1362045E (is)
RU (1)	RU2284326C2 (is)
SK (1)	SK10242003A3 (is)
WO (1)	WO2002066458A2 (is)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10107683A1 (de)	2001-02-19	2002-08-29	Merckle Gmbh Chem Pharm Fabrik	2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie
DE10222103A1 (de)	2002-05-17	2003-11-27	Merckle Gmbh Chem Pharm Fabrik	2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie
DE10238045A1 (de)	2002-08-20	2004-03-04	Merckle Gmbh Chem.-Pharm. Fabrik	2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie
DE10256881A1 (de) *	2002-12-05	2004-06-24	Beiersdorf Ag	Neue topische Verwendung von Bis-Arylimidazo[1,2-a]thiolanderivaten
ATE411989T1 (de)	2004-05-26	2008-11-15	Janssen Pharmaceutica Nv	Mercaptoimidazole als ccr2-rezeptorantagonisten
MXPA06013764A (es)	2004-05-26	2007-02-08	Janssen Pharmaceutica Nv	Mercaptoimidazoles como antagonistas del receptor ccr2.
JP2008509201A (ja) *	2004-08-11	2008-03-27	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	Ｃｃｒ２受容体アンタゴニストとしてのメルカプトイミダゾール
JP2008531627A (ja) *	2005-02-28	2008-08-14	メルクレ，ゲーエムベーハー	２−スルフィニル−および２−スルホニル置換イミダゾール誘導体およびサイトカイン阻害剤としてのそれらの使用
EP1894925A1 (en) *	2006-08-24	2008-03-05	Merckle Gmbh	Imidazole compounds having an antiinflammatory effect
WO2008085008A1 (en) *	2007-01-11	2008-07-17	Mogam Biotechnology Research Institute	T-cell inhibiting compounds and their use for the treatment of t-cell-mediated diseases
US8143294B2 (en) *	2007-12-31	2012-03-27	Michael Burnet	2-sulfanyl-substituted imidazole derivatives and their use as cytokine inhibitors
CN102249992A (zh) *	2011-07-05	2011-11-23	广东工业大学	一种制备2-氨基异烟酸的方法
DE102013102069A1 (de)	2013-03-01	2014-09-04	Fsp Fluid Systems Partners Holding Ag	Proportional-Wegeventil sowie hydraulische Schaltung und hydropneumatisches Federungssystem mit einem derartigen Ventil
US20190060286A1 (en)	2016-02-29	2019-02-28	University Of Florida Research Foundation, Incorpo	Chemotherapeutic Methods
US11739078B2 (en)	2019-02-22	2023-08-29	Insilico Medicine Ip Limited	Methods of inhibiting kinases

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL26729A (en) *	1965-10-21	1970-10-30	Geigy Ag J R	2-mercaptoimidazole derivatives and process for their preparation
US4190666A (en)	1975-08-11	1980-02-26	E. I. Du Pont De Nemours And Company	Anti-inflammatory 4,5-diarly-2-(substituted-thio)imidazoles and their corresponding sulfoxides and sulfones
DK16778A (da)	1977-02-09	1978-08-10	Du Pont	Imidazolderivater deres anvendelser og fremstilling
EP0004648B1 (de)	1978-04-11	1982-08-25	Ciba-Geigy Ag	Neue Mercaptoimidazolderivate, Verfahren zu deren Herstellung, Mercaptoimidazolderivate zur Behandlung entzündlicher Erkrankungen und diese enthaltende pharmazeutische Präparate
DE2823197A1 (de)	1978-05-24	1979-11-29	Schering Ag	Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3025484A1 (de)	1980-07-03	1982-02-04	Schering Ag, 1000 Berlin Und 4619 Bergkamen	Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3141063A1 (de)	1981-10-13	1983-04-28	Schering Ag, 1000 Berlin Und 4619 Bergkamen	Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3504678A1 (de)	1985-02-12	1986-08-14	A. Nattermann & Cie GmbH, 5000 Köln	Neue imidazolyl-oxyalkansaeuren und -thioalkansaeuren, ihre derivate und verfahren zu ihrer herstellung
US4686231A (en)	1985-12-12	1987-08-11	Smithkline Beckman Corporation	Inhibition of 5-lipoxygenase products
JPS6440467A (en)	1987-08-04	1989-02-10	Hisamitsu Pharmaceutical Co	Novel substituted diphenylimidazole derivative
FR2626691B1 (fr)	1988-02-02	1990-05-25	France Etat	Multiplieur numerique generalise et filtre numerique mettant en oeuvre ce multiplieur
JPH05503095A (ja)	1990-01-12	1993-05-27	ローン―プーラン・ロレ・ソシエテ・アノニム	イミダゾール類
IL104369A0 (en)	1992-01-13	1993-05-13	Smithkline Beecham Corp	Novel compounds and compositions
US5364875A (en)	1992-05-11	1994-11-15	The Du Pont Merck Pharmaceutical Company	Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis
US5474995A (en)	1993-06-24	1995-12-12	Merck Frosst Canada, Inc.	Phenyl heterocycles as cox-2 inhibitors
AU7629594A (en)	1993-07-21	1995-02-20	Smithkline Beecham Corporation	Imidazoles for treating cytokine mediated disease
US5620999A (en)	1994-07-28	1997-04-15	Weier; Richard M.	Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation
WO1999003837A1 (en) *	1997-06-30	1999-01-28	Ortho-Mcneil Pharmaceutical, Inc.	2-substituted imidazoles useful in the treatment of inflammatory diseases
DE19842833B4 (de)	1998-09-18	2005-04-14	Merckle Gmbh	2-Arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole und 2-Arylalkinylthio-imidazole als Entzündungs-Hemmstoffe und Hemmstoffe der Cytokin-Freisetzung
DE10107683A1 (de)	2001-02-19	2002-08-29	Merckle Gmbh Chem Pharm Fabrik	2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie

2001
- 2001-02-19 DE DE10107683A patent/DE10107683A1/de not_active Withdrawn
2002
- 2002-02-19 DK DK02716791T patent/DK1362045T3/da active
- 2002-02-19 CN CNB028051548A patent/CN1291984C/zh not_active Expired - Fee Related
- 2002-02-19 AT AT02716791T patent/ATE282605T1/de not_active IP Right Cessation
- 2002-02-19 JP JP2002565973A patent/JP2004521913A/ja active Pending
- 2002-02-19 IL IL15705002A patent/IL157050A0/xx unknown
- 2002-02-19 KR KR1020037010839A patent/KR100642231B1/ko not_active Expired - Fee Related
- 2002-02-19 MX MXPA03007380A patent/MXPA03007380A/es active IP Right Grant
- 2002-02-19 RU RU2003128068/04A patent/RU2284326C2/ru not_active IP Right Cessation
- 2002-02-19 ES ES02716791T patent/ES2233808T3/es not_active Expired - Lifetime
- 2002-02-19 AU AU2002247726A patent/AU2002247726C1/en not_active Ceased
- 2002-02-19 US US10/467,064 patent/US7253191B2/en not_active Expired - Fee Related
- 2002-02-19 BR BR0207254-8A patent/BR0207254A/pt not_active IP Right Cessation
- 2002-02-19 CZ CZ20032224A patent/CZ20032224A3/cs unknown
- 2002-02-19 PT PT02716791T patent/PT1362045E/pt unknown
- 2002-02-19 EP EP02716791A patent/EP1362045B1/de not_active Expired - Lifetime
- 2002-02-19 PL PL02367397A patent/PL367397A1/xx not_active Application Discontinuation
- 2002-02-19 HU HU0303155A patent/HUP0303155A3/hu unknown
- 2002-02-19 DE DE50201565T patent/DE50201565D1/de not_active Expired - Lifetime
- 2002-02-19 SK SK1024-2003A patent/SK10242003A3/sk not_active Application Discontinuation
- 2002-02-19 WO PCT/EP2002/001746 patent/WO2002066458A2/de not_active Ceased
- 2002-02-19 CA CA002453078A patent/CA2453078A1/en not_active Abandoned
2003
- 2003-08-15 IS IS6914A patent/IS6914A/is unknown

Also Published As

Publication number	Publication date
CN1291984C (zh)	2006-12-27
JP2004521913A (ja)	2004-07-22
CA2453078A1 (en)	2002-08-29
CZ20032224A3 (en)	2004-06-16
KR20030082940A (ko)	2003-10-23
BR0207254A (pt)	2004-02-10
KR100642231B1 (ko)	2006-11-02
CN1511149A (zh)	2004-07-07
PT1362045E (pt)	2005-04-29
HUP0303155A3 (en)	2007-08-28
MXPA03007380A (es)	2004-03-16
US7253191B2 (en)	2007-08-07
IL157050A0 (en)	2004-02-08
DK1362045T3 (da)	2005-03-29
WO2002066458A3 (de)	2002-12-12
DE10107683A1 (de)	2002-08-29
ATE282605T1 (de)	2004-12-15
RU2003128068A (ru)	2005-01-27
RU2284326C2 (ru)	2006-09-27
PL367397A1 (en)	2005-02-21
HK1056725A1 (en)	2004-02-27
ES2233808T3 (es)	2005-06-16
AU2002247726B2 (en)	2006-01-19
DE50201565D1 (de)	2004-12-23
SK10242003A3 (sk)	2004-03-02
WO2002066458A2 (de)	2002-08-29
HUP0303155A2 (hu)	2003-12-29
EP1362045B1 (de)	2004-11-17
US20040116416A1 (en)	2004-06-17
AU2002247726C1 (en)	2006-08-17
EP1362045A2 (de)	2003-11-19

Publication	Publication Date	Title
CY1109006T1 (el)	2014-07-02	Παραγωγα πουρινης ως αναστολεις κινασης
DK1200418T3 (da)	2004-07-26	Nematodicide trifluorbutener
DK1480961T3 (da)	2007-05-07	Glutaminylbaserede DPIV-inhibitorer
IS6914A (is)	2003-08-15	2-þíó-útskiptar imídasólafleiður og notkun þeirraí lyfjaiðnaðinum
ATE347555T1 (de)	2006-12-15	6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
DE69823493D1 (de)	2004-06-03	Tetrahydropyridoverbindungen
EA200000204A1 (ru)	2000-10-30	Производные пирролопирролона в качестве ингибиторов эластазы нейтрофилов
CY1109950T1 (el)	2014-09-10	Νεα παραγωγα 4,4-διθειοδις-(3-αμινοβουτανιο-1-σουλφονικων) και συνθεσεις που τα περιεχουν
ATE267816T1 (de)	2004-06-15	Tan-1057 derivate
ZA200708203B (en)	2008-10-29	2-Sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors
ATE298742T1 (de)	2005-07-15	Zykloalkenylsulfonamidderivate
YU22802A (sh)	2005-06-10	Izonipekotamidi za lečenje poremećaja nastalih posredstvom integrina
WO2003097633A8 (de)	2004-04-01	2-thio-substituierte imidazolderivate und ihre verwendung in der pharmazie
MXPA04001855A (es)	2004-06-15	Derivados de sistemas de indan-1-ol c2-sustituidos, metodos para la produccion de los mismos y su uso como medicamentos.
TW200503672A (en)	2005-02-01	2-aminobenzoyl derivatives
NO20026246D0 (no)	2002-12-27	2-aminoalkyl-tieno[2,3-d]pyrimidiner
ATE364037T1 (de)	2007-06-15	Tryptasehemmer
DK1551850T3 (da)	2006-09-25	2"-oxo-voruscharin og derivater deraf
ATE293107T1 (de)	2005-04-15	Luminacine analoge und deren verwendung
BR0201288A (pt)	2003-03-11	Derivados de piperazina